Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...
Resalis Therapeutics today announced the initiation of its first-in-human, Phase 1 study for RES-010, a non-coding RNA-based ...
Patrick Smith, President of Drug Development Solutions, Certara. Inflation and the Covid-19 pandemic have put pharmaceutical ...
For people battling cancer, getting a chance to take part in a research trial of a new treatment can sometimes make a big difference. Starting next year, patients at the Avera Cancer Institute in ...
Original research ranges from new concepts in human biology and disease pathogenesis to new therapeutic modalities and drug development, to all phases of clinical work, as well as innovative ...
DelveInsight's 'Myotonic Dystrophy Pipeline Insight 2024' report provides comprehensive global coverage of pipeline myotonic ...